title: Should rituximab be used to prevent relapse in patients with ANCA-associated vasculitis?
authors.affiliation: Renal and Vascular Inflammation Section, Department of Medicine, Imperial College London, London, United Kingdom.
authors.forename: Stephen P
authors.initials: SP
authors.lastname: McAdoo
authors.forename: Charles D
authors.initials: CD
authors.lastname: Pusey
mesh_terms: D056648:Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis / Q000188:drug therapy*; D058846:Antibodies, Monoclonal, Murine-Derived / Q000008:administration & dosage*; D001402:B-Lymphocytes / Q000187:drug effects*; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage*; D008297:Male; D000069283:Rituximab
chemical_list: D058846:Antibodies, Monoclonal, Murine-Derived; D007166:Immunosuppressive Agents; D000069283:Rituximab
keywords: ANCA; lymphocytes; vasculitis